Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Cabergoline Generic Name & Formulations
Legal Class
Rx
General Description
Cabergoline 0.5mg; scored tabs.
Pharmacological Class
Dopamine agonist.
How Supplied
Contact supplier.
Manufacturer
Cabergoline Indications
Indications
Hyperprolactinemic disorders, either idiopathic or due to pituitary tumors.
Cabergoline Dosage and Administration
Adult
Initially 0.25mg twice weekly. Dose may be increased at 4-week intervals by 0.25mg twice weekly. Max: 1mg twice weekly.
Children
Not established.
Cabergoline Contraindications
Contraindications
Uncontrolled hypertension. Sensitivity to ergot alkaloids.
Cabergoline Boxed Warnings
Not Applicable
Cabergoline Warnings/Precautions
Warnings/Precautions
Not for pregnancy-induced hypertension or postpartum lactation inhibition or suppression. Respiratory or cardiac disease due to fibrosis. Psychiatric disorders (eg, impulse control/compulsive behaviors, pathological gambling, increased libido). Hepatic impairment. Pregnancy. Nursing mothers: not recommended.
Cabergoline Pharmacokinetics
See Literature
Cabergoline Interactions
Interactions
Concurrent dopamine D2 antagonists (eg, phenothiazines, butyrophenones, thioxanthines, metoclopramide): not recommended. Hypotension may be potentiated by antihypertensives.
Cabergoline Adverse Reactions
Adverse Reactions
GI upset, dizziness, fatigue, postural hypotension, nervousness, breast pain, dysmenorrhea, vision abnormalities; rare: fibrosis, valvulopathy.
Cabergoline Clinical Trials
See Literature
Cabergoline Note
Notes
Formerly known under the brand name Dostinex.
Cabergoline Patient Counseling
See Literature
